4-phenoxy quinoline sulfonylurea compound, intermediate for synthesizing compound, and preparation method and application of compound

A technology of phenoxyquinoline and sulfonylureas, which is applied in organic chemistry, drug combination, antineoplastic drugs, etc., and achieves the effects of simple synthesis process, novel structure and good application prospects

Active Publication Date: 2019-07-09
威海海洋生物医药产业技术研究院有限公司
View PDF13 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Patents such as WO2004076412, WO2006021881, WO2010011538, and WO2010059771 all include a class of selective c-Met small molecule inhibitors, their preparation methods and uses. However, as tyrosine kinase inhibitors, especially c-Met inhibitors, never reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 4-phenoxy quinoline sulfonylurea compound, intermediate for synthesizing compound, and preparation method and application of compound
  • 4-phenoxy quinoline sulfonylurea compound, intermediate for synthesizing compound, and preparation method and application of compound
  • 4-phenoxy quinoline sulfonylurea compound, intermediate for synthesizing compound, and preparation method and application of compound

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0047] 1. The preparation of intermediate II compound: the nitro compound is obtained by the nucleophilic substitution reaction of p-nitrophenol or 2-fluoro-4-nitrophenol to the halogenated compound, and then obtained by reducing the nitro group. The specific reaction formula is as follows :

[0048]

[0049] Where: R 1 is selected from methyl, butyl, 3-morpholinopropyl, 3-(piperidin-1-yl)propyl, 3-(tetrahydropyrrol-1-yl)propyl; X is selected from hydrogen or fluorine.

[0050] 2. Preparation of intermediate III compound: react differently substituted benzyl chlorides and thiourea under ethanol reflux conditions for 3 to 5 hours, then evaporate the solvent under reduced pressure, add an appropriate amount of acetonitrile to dissolve, and cool to 0 o After C, N-chlorosuccinimide is added to obtain benzylsulfonyl chloride, which is reacted with ammonia to obtain sulfonamide, which is then reacted with ethyl chloroformate to obtain ethyl sulfonamidoformate, specifically The ...

Embodiment 1

[0063] Preparation compound: 1-[4-(6,7-dimethylquinoline-4-oxyl)phenyl]-3-(benzylsulfonyl)urea

[0064]

[0065] Step a: Synthesis of 6,7-dimethoxy-4-(4-nitrophenyloxy)quinoline, the reaction formula is as follows:

[0066]

[0067] Take 4-chloro-6,7-dimethoxyquinoline (671 mg, 3.0 mmol) and 4-nitrophenol (500 mg, 3.6 mmol ) in 7 mL of chlorobenzene, slowly heat to 140 o C, continue to react at this temperature for 20 h. Then stop heating, cool to room temperature, evaporate the solvent under reduced pressure, dissolve the residue with dichloromethane, wash with saturated potassium carbonate solution and water successively, dry over anhydrous sodium sulfate, concentrate under reduced pressure, and purify by silica gel column chromatography (PE / EA=3:1), 620 mg of light yellow solid was obtained, and the yield was 63%.

[0068] Step b: 4-[(6,7-Dimethoxy)quinoline-4-oxyl]aniline

[0069]

[0070] Weigh 6,7-dimethoxy-4-(4-nitrophenyl)quinoline (620 mg, 1.9 mmol) and d...

Embodiment 2

[0074] Example 2: Preparation of 1-[4-(6,7-dimethylquinoline-4-oxyl)phenyl]-3-[(4-fluorobenzyl)sulfonyl]urea

[0075]

[0076] The experimental procedure was the same as that in Example 1, except that ethyl p-fluorobenzylsulfonamide formate was used instead of ethyl benzylsulfonamide formate. White solid, yield: 46.4%. MP: 159-161 o c. 1 H NMR (400 MHz, DMSO- d 6 ) δ 8.94(s, 1H),8.48(d, J = 5.2 Hz, 1 H), 7.59 (d, J = 8.8 Hz, 1 H), 7.51 (s, 1 H), 7.43-7.39 (m, 3 H), 7.27-7.23 (m, 4 H), 6.46 (d, J = 5.2 Hz, 1 H), 4.77 (s, 2 H), 3.94 (s, 3 H), 3.93 (s, 3 H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of preparation of medical compounds, in particular to a 4-phenoxy quinoline sulfonylurea compound, an intermediate, and a preparation method and application of the compound. The compound is characterized in that the general formula of the compound is shown as a general formula (I) shown in the specification, and in the formula, R1 is selected from methyl, butyl, (3-morpholinyl)propyl, 3-(piperidin-1-yl)propyl, and 3-(tetrahydropyrrol-1-yl)propyl; x is selected from hydrogen and fluorine; and R2 is selected from phenyl, p-fluorophenyl, m-fluorophenyl, o-fluorophenyl, p-tolyl, m-tolyl, o-tolyl, p-chlorophenyl, p-bromophenyl, p-trifluoromethylphenyl and 3,4-trifluorophenyl. The compound has the advantages of being novel in structure, simple in synthesis process, high in product purity, high in inhibitory activity on tumor cells, good in application prospect and the like.

Description

technical field [0001] The invention relates to the technical field of preparation of medical compounds, specifically a 4-phenoxyquinoline with novel structure, simple synthesis process, high product purity, strong inhibitory activity on tumor cells, and excellent application prospects And sulfonylurea compounds, intermediates and their preparation methods and uses. Background technique [0002] As we all know, cancer is the number one killer threatening human life and health. Although the rapid progress of medicine has enabled human beings to have more means to treat diseases, cancer is still an unresolved medical problem. There are many causes of cancer, such as genetic factors, physical factors, chemical factors, etc. In recent years, scientific and technological The advances in the field of cancer have gradually elucidated the nature of tumor induction, and people have realized that the essence of cell cancer is the unlimited proliferation of cells caused by the imbalan...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): C07D215/22C07D413/12C07D401/12A61P35/00
CPCC07D215/22C07D413/12C07D401/12A61P35/00
Inventor李惠静吴彦超南翔
Owner威海海洋生物医药产业技术研究院有限公司